Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments [2 volumes

Edited by Michael J. Winkelman, Ph.D. and Thomas B. Roberts, Ph.D

Roberts's faculty webpage: Winkelmans' website:
Psychedelic substances present in nature have been used by humans across hundreds of years to produce mind-altering changes in thought, mood, and perception - changes we do not experience otherwise except rarely in dreams, religious exaltation, or psychosis. U.S. scientists were studying the practical and therapeutic uses for hallucinogens, including LSD and mescaline, in the 1950s and 1960s supplied by large manufacturers including Sandoz. But the government took steps to ban all human consumption of hallucinogens, and thus the research. By 1970s, all human testing was stopped. Medical concerns were not the issue, the ban was moved by social concerns, not the least of which were created by legendary researcher Timothy Leary, a psychologist who advocated free use of hallucinogens by all who desired. Nationwide, however, a cadre of scholars and researchers has persisted in pushing the federal government to again allow human testing. And the moratorium has been lifted. The FDA has begun approving hallucinogenic research using human subjects. In these groundbreaking volumes, top researchers explain the testing and research underway to use - under the guidance of a trained provider - psychedelic substances for better physical and mental health.

The result is an impressive collection. University of Pennsylvania Center for Bioethics “Roberts and Winkelman have assembled one of the most impressive and comprehensive collection of writings in the field of psychedelic medicine. clinicians. PhD Professor. Psychiatry. The chapters. most of whom have had direct experience using and administering these drugs in either therapeutic or religious contexts. The contributors to this volume make a persuasive case that science should now do more to pursue these questions. mental health professionals. and spirituality makes them uniquely suited for this purpose.Stephen Ross. written by first-rate academic scholars.D. NYU School of Medicine “These volumes present fresh ideas for using psychedelic drugs as therapeutic agents to treat some of the most intractable of psychological ailments.” -. Ph. and ethical implications of using this novel class of agents.Nicholas V. are rigorous and clear. Likely to be of interest to scientists. Division of Alcoholism and Drug Abuse. feelings. Undoubtedly. and anyone interested in the mind. Department of Pharmacology University of Wisconsin School of Medicine and Public Health Psychedelic Medicines: New Evidence for Hallucinogenic Substances as Treatments . spiritual. researchers. and clinicians.” --Harriet de Wit. Cozzi. Thanks to these forward-thinking educators. the ability of these substances to facilitate direct experiential access to our deepest thoughts. Addiction Psychiatry Fellowship. The contributors represent an outstanding group of scientists. This book is an invaluable resource for educators. It provides an up to date review of the status of h allucinogens in modern medicine. Assistant Clinical Professor. As the authors make clear. It is highly recommended. medicinal. The topics range from neuroscience to the legal. Bellevue Hospital Associate Director.“These books are a comprehensive and scholarly review of the current status of the therapeutic potential of hallucinogens.D. their amazing healing potential has yet to be fully realized. Moreno.Professor Jonathan D. Department of Psychiatry The University of Chicago “Until they were caught up in the cultural revolution of the 1960s. we now have new paths to explore in the cure for old diseases. The authors provide a balanced view and acknowledge the many risks and pitfalls of improper use of these drugs. hallucinogens were being seriously examined by top researchers for their potential to alleviate many human ills. clergy. as well as a historical review of their status in the past. scholars and clinicians. The authors provide scholarly historical reviews of the use of these drugs. and policy makers who are interested in rejuvenating the field of psychedelic research. as well as detailed instructions and advice for the clinician on how to administer these drugs safely and effectively in a therapeutic context. M.” -. NYU School of Medicine Director.” -.

George Greer & Requa Tolbert Chapter 8: MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder. Michael Winkelman Chapter 2: The Healing Vine: Ayahuasca as Medicine in the 21st Century. & Roberts. Richard Boire 13: The Legal Bases for Religious Peyote Use. Andrew Sewell & John H. Torsten Passie Chapter 4: Therapeutic Guidelines: Dangers and Contra-Indications in Therapeutic Applications of Hallucinogens.Lancet Editorial Chapter 1: Introduction — The Adventure Continues. A. Roberts Editor’s Overview of Psychedelic Medicines Volume 1.Winkelman. Thomas B. C. Michael. Moreno & P. Thomas B. CT: Praeger/Greenwood Publishers Volume I: Psychedelic Medicine: Social. Westport. Donald Abrams Chapter 11: The Use of Psilocybin in Patients with Advanced Cancer and Existential Anxiety. Dennis McKenna Chapter 3: Contemporary Psychedelic Therapy: An Overview. Michael Mithoefer Chapter 9: Psychedelic Drugs for the Treatment of Depression. Alberto Groisman & Marlene de 15: Conclusions. Michael Winkelman Section I: The Social and Clinical Context Chapter 1: Therapeutic Bases of Psychedelic Medicines: Psychointegrative Effects. (editors) (2007). Kevin Feeney 14: The Supreme Court’s Psychedelic Case. Thomas B. Delgado Chapter 7: Therapeutic Uses of MDMA.Compulsive Disorder. Michael Winkelman & Thomas B. L. Halpern Chapter 6: Psilocybin Treatment of Obsessive. Ede Frecska Section II: Medical Applications Chapter 5: Response of Cluster Headaches to Psilocybin and LSD. Michael Montagne Chapter 10: Marijuana and AIDS. F. Roberts Volume II: Psychedelic Medicine: Addictions Medicine and Transpersonal Healing Preface. Clinical and Legal Perspectives Preface-Warning. Roberts Section I: Treating Substance Abuse . Grob Chapter Chapter Chapter Rios Chapter Section III: Legal Aspects of the Medical Use 12: Psychedelic Medicine and the Law.

Alper & Howard Lotsof Chapter 6: Ketamine Psychedelic Psychotherapy. H. Evgeny Krupitsky & Eli Kolp Chapter 7: Ayahuasca Treatment of Cocaine-Paste Addiction. Jesse.Chapter 2: Hallucinogens in the Treatment of Alcoholism and Other Addictions. Dryer Chapter 4: The Therapeutic Use of Peyote in the Native American Church. Neal Goldsmith Chapter 9: Therapeutic Guidelines from Shamanic Traditions. Kenneth R. or use this order form: .com. Dan Merkur Section III: Transpersonal Dimension of Healing with Psychedelic Medicines Chapter 12: Psychedelics in Psychological Health and Growth. Despair. R. W. Roger Marsden & David Lukoff Chapter 16: Conclusions and Future Recommendations: The Wider Contexts. Richards. Thomas B. McCann & R. Sean House Chapter 11: Preliminary Remarks on Interpreting Resistance to Psychedelic Insights.greenwood. Griffiths. Halpern Chapter 3: Addiction. call 1-800-225-5800. and the Soul: Psychedelic Psychotherapy. Chapter 14: Remarkable Healing During Psychedelic Psychotherapy. Jacques Mabit Section II: Guidelines for Psychotherapeutic Applications Chapter 8: The Ten Lessons of Psychedelic Psychotherapy… Rediscovered. U. R. Michael Winkelman Chapter 10: Common Processes in Psychospiritual Change. J. Roberts Author biographies Index List Price: $200. Yensen & D. Stanislav Grof Chapter 15: Transpersonal Healing with Hallucinogens.00 0-275-99023-0/978-0-275-99023-7 Pages: Publication: 6/30/2007 To order. Roger Walsh & Charles Grob Chapter 13: Psilocybin Can Occasion Mystical-type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance. visit www. Joseph Calabrese Chapter 5: Ibogaine and Substance Abuse Rehabilitation.

please add shipping and handling: U. VT residents add sales tax on subtotal.Name: Address: City: State: Zip: Telephone: Email: Check enclosed made payable to Greenwood Publishing Group Charge Credit Card: VISA AMEX Credit Card #: Expiration Date: Signature (required): MC ISBN Title Price $200.S. .00 Subtotal Shipping Sales Tax Total Qt y Total 0-275-99023-0 Psychedelic Medicine 978-0-275-99023-7 [Two Volumes] If paying by check. NJ. MD. $8. CT. residents add 10%. Canada residents add GST tax. IL. CO. MA. add 12%. PA. MO.00 minimum. Enclose taxexempt certificate if applicable. Canada residents. & SD residents add sales tax on subtotal plus shipping charges.

Sign up to vote on this title
UsefulNot useful